Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individuals

Bron
Journal of thrombosis and haemostasis - ISSN 1538-7933-21:5 (2023) p. 1266-1273
Auteur(s)

Activation of the carboxypeptidase U (CPU, TAFIa, CPB2) system in patients with SARS-CoV-2 infection could contribute to COVID-19 hypofibrinolytic state and disease severity prognosis

Bron
Journal of Clinical Medicine - ISSN 2077-0383-11:6 (2022) p. 1-11
Auteur(s)

Pleiotropic effects of Atorvastatin result in a downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a mouse model of advanced atherosclerosis

Bron
Pharmaceutics - ISSN 1999-4923-13:10 (2021) p.
Auteur(s)